Cytosorbents Corporation (CTSO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Cytosorbents Corporation

NASDAQ: CTSO · Real-Time Price · USD
0.93
0.00 (0.42%)
At close: Sep 26, 2025, 3:59 PM
0.93
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

Cytosorbents Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.28M 14.13M 22.14M 52.14M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
1.48M 1.48M 1.73M 1.94M
Other Long-Term Assets
22.64K 52.05K 1.73M 1.94M
Receivables
7.32M 6.06M 5.66M 4.52M
Inventory
2.73M 3.38M 3.46M 4.77M
Other Current Assets
8.27M n/a 462.00 -85
Total Current Assets
21.6M 25.4M 33.76M 64.3M
Property-Plant & Equipment
20.51M 22.12M 23.35M 18.57M
Goodwill & Intangibles
3.75M 3.91M 4.39M 4.7M
Total Long-Term Assets
25.77M 27.56M 29.47M 25.22M
Total Assets
47.37M 52.96M 63.23M 89.52M
Account Payables
3.34M 3.8M 1.66M 2.81M
Deferred Revenue
419.33K 1.38M 1.52M 1.95M
Short-Term Debt
452.69K 2.5M 108.94K 570.57K
Other Current Liabilities
412.82K 991.54K -108.49K 687.5K
Total Current Liabilities
9.82M 14.04M 9.71M 13.69M
Long-Term Debt
14M 2.54M 5M n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
26.44M 15.44M 18.14M 13.25M
Total Liabilities
36.26M 29.48M 27.86M 26.94M
Total Debt
26.89M 18.31M 18.25M 13.82M
Book Value
11.11M 23.48M 35.38M 62.58M
Book Value Per Share
0.20 0.53 0.81 1.44
Common Stock
54.83K 54.24K 43.63K 43.48K
Retained Earnings
-304.01M -282.51M -254M -221.19M
Comprehensive Income
4.25M 529.32K 2.33M 525.59K
Shareholders Equity
11.11M 23.48M 35.38M 62.58M
Total Investments
1.48M 1.48M 1.73M 1.94M